AI-assisted research summary: This Law amends Article 8 of the Medicines (Jersey) Law 1995 and changes how certain marketing authorization conditions about prescription-only, pharmacy-only, or general-sale availability are treated. It also starts on a day appointed by the States.
L.10/2005 Medicines (Amendment No. 2) (Jersey) Law 2005 A LAW to amend further the Medicines (Jersey) Law 1995 . Adopted by the States 1st February 2005 Sanctioned by Order of Her Majesty in Council 7th May 2005 Registered by the Royal Court 10th June 2005 THE STATES , subject to the sanction of Her Most Excellent Majesty in Council, have adopted the following Law – 1 Article 8 amended In Article 8 of the Medicines (Jersey) Law 1995 [1] – (a) in paragraph (1)(c) for the full stop at the end of the sub-paragraph there shall be substituted the word “; and”; (b) after paragraph (1)(c) there shall be added the following sub-paragraph – “(d) the provisions of Part IV and any Order made under that Part.”; and (c) after paragraph (2) there shall be inserted the following paragraph – “(2A) Where a medicinal product is subject to a marketing authorization and it is a condition of the marketing authorization that the product is to be available on one or more of the following bases – (a) only on prescription; (b) only from a pharmacy; or (c) on general sale, that condition shall have effect, unless an Order made under Part IV prescribes otherwise, as if any such basis was prescribed by an Order made under Article 57, had effect as a consequence of Article 51 or was prescribed by an Order made under Article 50 as the case may be. 2 Citation and commencement This Law may be cited as the Medicines (Amendment No. 2) (Jersey) Law 2005 and shall come into force on such day as the States may by Act appoint. A.H. HARRIS Deputy Greffier of the States. [1] Volume 1994-1995, page 450.